New Therapeutic Paradigme

Genexion SA
81, route de Florissant
1206 Geneve

Auf Karte anzeigen
Öffnungszeiten
MO - FR: 08:00 - 17:00
Firmenbeschrieb
Genexion SA is a privately owned clinical development company engaged in the development of new biopharmaceutical products, specifically targeting autoimmune and chronic inflammatory diseases. Genexion has developed a high-performance clinical development platform that fully integrates the scientific, strategic, operational, and financial aspects of product development in selected therapeutic areas. Genexion's clinical development capabilities feature a comprehensive range of strategic and operational solutions covering the whole clinical development process to help biopharmaceutical companies and smaller organizations optimize their product development programs.

„Für unsere Kunden sind wir einzigartig, weil over 30 years of clinical development experience, with a record of several biologics brought to market. A unique network of investigators in emerging countries including LATAM and Eastern Europe Focused clinical research operations in early clinical development phases and proof-of-concept trials. A renowned scientific and medical advisory board formed by worldwide experts in the fields of chronic inflammatory and autoimmune diseases.“

Gründungsjahr
2004
 
Anzahl Mitarbeiter
13
 


Marktleistungen
  • Clinical Development Strategies
    Genexion brings an exceptional center of expertise in the development of new therapeutic paradigms for autoimmune and chronic inflammatory diseases. Together with a unique network of scientific and clinical partners, Genexion designs and executes clinical development strategies to efficiently move from pre-clinical to registration.
  • Clinical Research Operations
    Genexion provides clinical research operations built to streamline the development of products targeting autoimmune and chronic inflammatory diseases. Solutions are tailored to integrate operational efficiency as well as the marketing requirements of partners and clients.
  • Product Development Tools
    In collaboration with leading institutions, Genexion offers specialized investigations, study modeling and disease read outs that provide additional independent and objective data, increasing the information content and predictive value of early clinical trials
Kundengruppen
  • Small Biotech companies
    Small biotech companies entering in clinical development stages and looking for partnering with an organization to design and execute clinical development program
  • Mid-size/large biopharma
    Companies interested to outsource part of their clinical development programs for strategical and technical reasons
  • Investor active in biotech sector
    Venture capitalists and other investment organizations active in the biotech sector wishing to access scientific and clinical know-how to optimize clinical development programs and maximize their ROI
Mehr über uns
Eintrag erstellt: 25.01.2005, Letzte Änderung: 22.07.2005